Is sentinel lymph node biopsy after neoadjuvant chemotherapy feasible in Chinese patients with invasive breast cancers?

ANZ Journal of Surgery

Volumn 79, Issue 10, 2009, Pages 719-723

  Cheung, Tanfo T ^a   Suen, Dacita T K ^a   Kwong, Ava ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Axillary dissection; Breast cancer; Chinese; False negative rate; Lymphatic mapping; Neoadjuvant chemotherapy; Sentinel lymph node biopsy

Indexed keywords

CYCLOPHOSPHAMIDE; DISULFINE BLUE; DOXORUBICIN; RADIOPHARMACEUTICAL AGENT; TAXANE DERIVATIVE; TECHNETIUM ALBUMIN COLLOID TC 99M; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CHINESE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; REVIEW; SENTINEL LYMPH NODE BIOPSY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; INCIDENCE; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 70350498908     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2009.05057.x     Document Type: Review

References (31)

1. Mamounas EP. NSABP breast cancer clinical trials: recent results and future directions. Clin. Med. Res. 2003 1 : 309 326.
2. Krag DN, Julian TB, Harlow SP et al. NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial. Ann. Surg. Oncol. 2004 11 : 208S 10S.
3. Haid A, Tausch C, Lang A et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001 92 : 1080 1084.
4. Tafra L, Lannin DR, Swanson MS et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann. Surg. 2001 233 : 51 9.
5. Chagpar AB, Martin RC, Scoggins CR et al. Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery 2005 138 : 56 63.
6. Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am. J. Surg. 2001 182 : 312 315. (Pubitemid 33079077)
7. Mamounas EP, Bryant J, Lembersky B et al. Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. J. Clin. Oncol. 2005 23 : 3686 3696.
8. Fisher B, Bryant J, Wolmark N et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J. Clin. Oncol. 1998 16 : 2672 2685.
9. Fisher B, Brown A, Mamounas E et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J. Clin. Oncol. 1997 15 : 2483 2493.
10. Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am. J. Surg. Pathol. 2000 24 : 1266 1272.
11. Nason KS, Anderson BO, Byrd DR et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000 89 : 2187 2194.
12. Tausch C, Konstantiniuk P, Kugler F et al. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann. Surg. Oncol. 2006.
13. Breslin TM, Cohen L, Sahin A et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J. Clin. Oncol. 2000 18 : 3480 3486.
14. Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J. 2002 8 : 97 100.
15. Julian TB, Patel N, Dusi D et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am. J. Surg. 2001 182 : 407 410.
16. Piato JR, Barros AC, Pincerato KM, Sampaio AP, Pinotti JA. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur. J. Surg. Oncol. 2003 29 : 118 120.
17. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann. Surg. Oncol. 2002 9 : 235 242.
18. Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am. J. Surg. 2002 184 : 315 317.
19. Krag DN. The sentinel node for staging breast cancer: current review. Breast Cancer 1999 6 : 233 236.
20. Patel NA, Dusi D, Bragdon G, Julian TB. Technical limitations of sentinel node biopsy in breast cancer: a single surgeon's experience. Am. Surg. 2003 69 : 111 116.
21. Weaver DL, Krag DN, Manna EA et al. Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. An NSABP protocol B-32 quality assurance study. Cancer 2006 107 : 661 667.
22. Kwong A, Cheung PS, Wong AY et al. The acceptance and feasibility of breast cancer screening in the East. Breast 2008 17 : 42 50.
23. Harlow SP, Krag DN. Sentinel lymph node biopsy in breast cancer. Breast Dis. 2001 12 : 43 55.
24. Lyman GH, Giuliano AE, Somerfield MR et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J. Clin. Oncol. 2005 23 : 7703 7720.
25. Mamounas EP, Brown A, Anderson S et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J. Clin. Oncol. 2005 23 : 2694 2702.
26. Kinoshita T. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer 2007 14 : 10 5.
27. Fernandez A, Cortes M, Benito E et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl. Med. Commun. 2001 22 : 361 366.
28. Gimbergues P, Abrial C, Durando X et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann. Surg. Oncol. 2008 15 : 1316 1321.
29. Vendrell-Torne E, Setoain-Quinquer J, Domenech-Torne FM. Study of normal mammary lymphatic drainage using radioactive isotopes. J. Nucl. Med. 1972 13 : 801 805.
30. Qiao Q, Ling Y, Zhou G, Song R. Breast volume measurement in 125 young Chinese women. Chin. Med. Sci. J. 1992 7 : 44 8.
31. Cody HS III. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann. Surg. 2006 244 : 324 325.